A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
|ClinicalTrials.gov Identifier: NCT00812006|
Recruitment Status : Completed
First Posted : December 19, 2008
Results First Posted : January 27, 2011
Last Update Posted : June 6, 2017
|Study Design||Allocation: Randomized; Intervention Model: Crossover Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment|
Drug: rizatriptan benzoate
Drug: Comparator: placebo
First Patient In: 26 March 2009; Last Patient Last Visit: 22 October 2009.
17 Outpatient centers worldwide (10 United States; 2 Canada; 2 Spain, 2 Italy; 1 France)
Participants were assessed, using the protocol inclusion and exclusion criteria, at Visit 1, and if eligible,
were randomized at the same visit.